Venture Building · Agri / Bio / AI

The AI-native infrastructure for Earth's living systems.

Building the venture platform for a $100 trillion biological economy

Agriculture, biotechnology, diagnostics, longevity, climate technologies, and AI are converging to create one of the largest economic transformations of the 21st century. We believe this emerging biological economy represents a $100 trillion global opportunity over the coming decades.

AgriBioVentures is building the AI-native venture platform that connects breakthrough science, visionary founders, patient capital, and global commercialization to accelerate this transformation.

Order: Venture Building Class: Deep Science Domain: Agritech · Biotech · Diagnostics · Climate · Longevity · AI
Agritech◆Biotechnology◆Diagnostics◆Climate Systems◆Human Health◆AI for Biology◆Venture Building◆Agritech◆Biotechnology◆Diagnostics◆Climate Systems◆Human Health◆AI for Biology◆Venture Building◆
Vision 2036

Our vision: building a $1 trillion venture platform by 2036.

Our long-term ambition is to establish AgriBioVentures as the world's leading AI-native venture platform for Earth's living systems, creating a portfolio of category-defining companies across agriculture, biotechnology, human health, diagnostics, climate, and deep science.

Through disciplined venture creation, strategic investments, scientific validation, and global partnerships, our aspiration is to build a venture ecosystem capable of creating $1 trillion in enterprise value by 2036.

$1T
Aspirational enterprise value · 2036
Horizon2026 → 2036
ApproachVenture creation + capital + science
Measured byCombined ecosystem enterprise value
About the venture

Conviction over volume, science over speculation.

We combine hands-on venture-building experience with deep domain expertise to help early-stage companies scale from promising science into market-ready, impact-driven businesses.

Rather than optimizing for deal volume, our platform is built around conviction — backing founders and technologies grounded in years of scientific research, validation, proprietary know-how, and intellectual property.

We prioritize companies with genuine, defensible barriers to entry: proprietary technologies, unique formulations, patentable innovations, proprietary datasets and AI models, and rigorously validated science.

Focus stageSeed → Pre-Series A
SectorsAgritech, Biotech, Diagnostics
Also coversClimate, AI for Biology
Beyond capitalCommercialization, GTM, IP
AccessGrants, Ecosystem, Capital
HorizonBuilt to compound over decades
Leadership

Scientific rigor, paired with long-horizon conviction.

Kamalendu Singh
Co-Founder & Managing Partner

Kamalendu Singh

LinkedIn ↗

Kamalendu leads AgriBioVentures with a conviction-driven, long-horizon approach to venture building at the convergence of AI, agriculture, biotechnology, diagnostics, climate systems, and human health — sectors he views as merging into a single "biological economy." His investment thesis prioritizes genuine, defensible barriers to entry: proprietary technology, IP, and rigorously validated science. Beyond capital, he directs the firm's work in venture building, commercialization, strategic partnerships, and capital access.

Venture BuildingAI for Biological SystemsIP-Driven ThesisEcosystem & Capital Access
Bhuvana Sharma
Co-Founder & Chief Scientific Officer

Bhuvana Sharma

LinkedIn ↗

A research scientist and academic with 14 years across some of India's leading scientific institutions — IISc Bangalore, the National Institute of Nutrition, NCBS, and Kidwai Memorial Institute of Oncology. Her technical expertise spans RT-qPCR, flow cytometry, and FISH studies across multiple cancer types. As CSO, Bhuvana leads AgriBioVentures' scientific and technical due diligence, anchoring the firm's rigor in evaluating and developing agri-biotech innovation from early research through commercial viability.

Molecular BiologyRT-qPCRFlow CytometryScientific Due Diligence
Strategic Advisors

Operating experience across enterprise, agritech, and digital commerce.

Priyanka Singh
Strategic Advisor

Priyanka Singh

LinkedIn ↗

A technology and business transformation leader with 18+ years across financial services, enterprise technology, and digital transformation, including leadership roles at Tata Steel, Barclays, BlackRock, and Air India. An alumna of IIT Kanpur and IIM Kolkata, and Co-Founder of XcelGrad. At AgriBioVentures, she advises on organizational strategy, venture scaling, and operational excellence.

Digital TransformationVenture ScalingEnterprise Strategy
Deepak Verma
Strategic Advisor

Deepak Verma

LinkedIn ↗

An entrepreneur and technology leader with 18+ years across agritech, B2B commerce, and banking, including senior roles at Zomato Hyperpure and as Agriculture Business Lead at ONDC. An alumnus of IIT Kharagpur and IIM Indore, and Founder of XcelGrad. At AgriBioVentures, he guides agritech innovation, commercialization, and go-to-market strategy.

Agritech & Food SystemsDigital CommerceGo-to-Market
Lalith Kishore
Advisor — Biotechnology Innovation, Life Sciences & Commercialization

Lalith Kishore

LinkedIn ↗

A biotechnology business leader with over two decades of experience spanning genomics, drug discovery, molecular diagnostics, and life-sciences commercialization. Currently with the Centre for Cellular and Molecular Platforms (C-CAMP), India's premier biotechnology innovation ecosystem, he works closely with startups, researchers, investors, and government agencies to accelerate deep-science innovation and technology transfer. At AgriBioVentures, he advises on biotechnology commercialization, translational research, and global life-sciences partnerships.

Biotech CommercializationGenomics & Precision MedicineDeepTech Venture Building

We don't believe the next trillion-dollar companies will emerge from software alone. They will emerge from biology, agriculture, AI, and human health. AgriBioVentures exists to help build them.